EXPERIMENTAL IMMUNOLOGY
Differentiated all-trans retinoic acid response of naive CD4+CD25– cells isolated from rats with collagen-induced arthritis and healthy ones under in vitro conditions
Submission date: 2015-12-31
Final revision date: 2016-05-28
Acceptance date: 2016-05-28
Publication date: 2017-05-08
Cent Eur J Immunol 2017;42(1):39-53
KEYWORDS
ABSTRACT
Aim o the study: To compare the potential of CD4+CD25– cells, isolated from both healthy rats and rats with CIA (Collagen-Induced Arthritis), for differentiation into regulatory T cells in the presence of all-trans retinoic acid in order to learn more about the activation mechanisms and therapeutic potential of regulatory T cells.
Material and methods: Sorted CD4+CD25– cells were cultured in vitro with/without ATRA, and then the frequency of regulatory T cells and their ability to secrete IL-10 by CD4+ FOXP3+ cells was examined. Gene expression of the foxp3, rarα, rarβ, rxrβ, and ppar β/γ and protein expression of the Rarα, Rarβ, and Rxrβ in cells after stimulation with ATRA were also investigated.
Results: CD4+CD25– cells isolated from healthy animals or from animals with CIA are characterised by different potential of the differentiation into CD4+CD25+ FOXP3+ cells. Retinoic acid receptor Rxrβ is present in the CD4+CD25– cells isolated from rats with CIA.
Conclusions: We showed that although ATRA did not increase the frequency of Treg in culture, it significantly increased expression of rarα and rxrβ only in lymphocytes taken from diseased animals and foxp3 expression only in healthy animals. Moreover, after ATRA stimulation, the frequency of Treg-produced IL-10 tended to be lower in diseased animals than in the healthy group. The results imply that the potential of naïve cell CD4 lymphocytes to differentiate into Tregs and their putative suppressive function is dependent on the donor’s health status.
Material and methods: Sorted CD4+CD25– cells were cultured in vitro with/without ATRA, and then the frequency of regulatory T cells and their ability to secrete IL-10 by CD4+ FOXP3+ cells was examined. Gene expression of the foxp3, rarα, rarβ, rxrβ, and ppar β/γ and protein expression of the Rarα, Rarβ, and Rxrβ in cells after stimulation with ATRA were also investigated.
Results: CD4+CD25– cells isolated from healthy animals or from animals with CIA are characterised by different potential of the differentiation into CD4+CD25+ FOXP3+ cells. Retinoic acid receptor Rxrβ is present in the CD4+CD25– cells isolated from rats with CIA.
Conclusions: We showed that although ATRA did not increase the frequency of Treg in culture, it significantly increased expression of rarα and rxrβ only in lymphocytes taken from diseased animals and foxp3 expression only in healthy animals. Moreover, after ATRA stimulation, the frequency of Treg-produced IL-10 tended to be lower in diseased animals than in the healthy group. The results imply that the potential of naïve cell CD4 lymphocytes to differentiate into Tregs and their putative suppressive function is dependent on the donor’s health status.
REFERENCES (59)
1.
Abbas AK, Benoist C, Bluestone JA, et al. (2013): Regulatory T cells: recommendations to simplify the nomenclature. Nat Immunol 14: 307-308.
2.
von Herrath MG, Harrison LC (2003): Antigen-induced regulatory T cells in autoimmunity. Nat Rev Immunol 3: 223-232.
4.
Sakaguchi S (2011): Regulatory T cells: history and perspective. In: Regulatory T cells. Humana Press 707: 3-17.
5.
Clarke N, Germain P, Altucci L, et al. (2004): Retinoids: potential in cancer prevention and therapy. Expert Rev Mol Med 6: 1-23.
6.
Niedbala W, Wei XQ, Cai B, et al. (2007): IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 37: 3021-3029.
7.
Maynard CL, Hatton RD, Helms WS, et al. (2009): Contrasting roles for all-trans retinoic acid in TGF-–mediated induction of Foxp3 and Il10 genes in developing regulatory T cells. J Exp Med 206: 343-357.
8.
Cui D, Moldoveanu Z, Stephensen CB (2000): High-level dietary vitamin A enhances T-helper type 2 cytokine production and secretory immunoglobulin A response to influenza A virus infection in BALB/c mice. J Nutr 130: 1132-1139.
9.
Min SY, Hwang SY, Park KS, et al. (2004) Induction of IL-10-producing CD4+ CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen. Arthritis Res Ther 6: R213-R219.
10.
Walmsley M, Katsikis PD, Abney E, et al. (1996): Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum 39: 495-503.
11.
Kochetkova, I, Golden S, Holderness K, et al. (2010): IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10.
13.
Venken K, Hellings N, Thewissen M, et al. (2008): Compromised CD4+ CD25high regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. Immunology 123: 79-89.
14.
Kawashiri SY, Kawakami A, Okada A, et al. (2011): CD4+ CD25highCD127low/– Treg cell frequency from peripheral blood correlates with disease activity in patients with rheumatoid arthritis. J Rheumatol 38: 2517-2521.
15.
Peters J, Koenen HJ, Hilbrands LB, et al. (2009): Immunotherapy with regulatory T cells in transplantation. Immunotherapy 1: 855-857.
16.
Morgan ME, Flierman R, van Duivenvoorde LM, et al. (2005): Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum 52: 2212-2221.
17.
Kohm AP, Carpentier PA, Anger HA, et al. (2002): Cutting edge: CD4+ CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol 169: 4712-4716.
18.
Mukherjee R, Chaturvedi P, Qin HY, et al. (2003): CD4+ CD25+ regulatory T cells generated in response to insulin B: 9–23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells. J Autoimmun 21: 221-237.
19.
Felcenloben I, Piasecki T, Miller J, et al. (2015): Adoptively transferred Tregs accumulate in a site-specific manner and ameliorate signs of less advanced collagen-induced arthritis progress in rats. Immunotheraphy 7: 215-228.
20.
Lu L, Ma J, Li Z, et al. (2011): All-trans retinoic acid promotes TGF--induced Tregs via histone modification but not DNA demethylation on Foxp3 gene locus. PLoS One 6: e24590.
21.
Scottà C, Esposito M, Fazekasova H, et al. (2013): Differential effects of rapamycin and retinoic acid on expansion, stability and suppressive qualities of human CD4+ CD25+ FOXP3+ T regulatory cell subpopulations. Haematologica 98: 1291-1299.
22.
Germain P, Chambon P, Eichele G, et al. (2006): International union of pharmacology. LX. Retinoic acid receptors. Pharmacol Rev 58: 712-725.
23.
Schenk T, Stengel S, Zelent A (2014): Unlocking the potential of retinoic acid in anticancer therapy. Br J Cancer 111: 2039-2045.
24.
Lanvers C, Hempel G, Blaschke G, et al. (1998): Chemically induced isomerization and differential uptake modulate retinoic acid disposition in HL-60 cells. FASEB J 12: 1627-1633.
25.
Idres N, Marill J, Flexor MA, et al. (2002): Activation of retinoic acid receptor-dependent transcription by all-trans-retinoic acid metabolites and isomers. J Biol Chem 277: 31491-31498.
26.
Ballow M, Wang X, Xiang S, et al. (2003): Expression and regulation of nuclear retinoic acid receptors in human lymphoid cells. J Clin Immunol 23: 46-54.
27.
Coombes JL, Siddiqui KR, Arancibia-Cárcamo CV, et al. (2007): A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF- and retinoic acid-dependent mechanism. The J Exp Med 204: 1757-1764.
28.
Mucida D, Cheroutre H (2007): TGFbeta and retinoic acid intersect in immune-regulation. Cell Adh Migr. 1: 142-144.
29.
Sun CM, Hall JA, Blank RB, et al. (2007): Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 204: 1775-1785.
30.
Hall JA, Cannons JL, Grainger JR, et al. (2011): Essential role for retinoic acid in the promotion of CD4+T Cell effector responses via retinoic acid receptor alpha. Immunity 34: 435-447.
31.
Suszko A, Obmińska-Mrukowicz B (2013): Influence of polysaccharide fractions isolated from Caltha palustris L. on the cellular immune response in collagen-induced arthritis (CIA) in mice. A comparison with methotrexate. J Ethnopharmacol 145: 109-117.
32.
Benson MJ, Pino-Lagos K, Rosemblatt M, et al. (2007): All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med 204: 1765-1774.
33.
Kwok SK, Park MK, Cho ML, et al. (2012): Retinoic acid attenuates rheumatoid inflammation in mice. J Immunol 189: 1062-1071.
34.
Zhou X, Kong N, Wang J, et al. (2010): Cutting edge: all-trans retinoic acid sustains the stability and function of natural regulatory T cells in an inflammatory milieu. J Immunol 185: 2675-2679.
35.
Yang Z, Matteson EL, Goronzy JJ, et al. (2015): T-cell metabolism in autoimmune disease Arthritis Res Ther 17: 29.
36.
Straub RH (2014): Insulin resistance, selfish brain, and selfish immune system: an evolutionarily positively selected program used in chronic inflammatory diseases. Arthritis Res Ther 16 (Suppl 2): S4.
37.
Michalek RD, Gerriets VA, Jacobs SR, et al. (2011): Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J Immunol 186: 3299-3303.
38.
Keystone E, Wherry J, Grint P (1998): IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis. Rheum Dis Clin North Am 24: 629-639.
39.
Maynard CL, Hatton RD, Helms WS, et al. (2009): Contrasting roles for all-trans retinoic acid in TGF--mediated induction of Foxp3 and Il10 genes in developing regulatory T cells. J Exp Med 206: 343-357.
40.
Adamson PC (1996): All-trans-retinoic acid pharmacology and its impact on the treatment of acute promyelocytic leukemia. Oncologist 1: 305-314.
41.
Takeyama K, Kojima R, Ohashi T, et al. (1996): Retinoic acid differentially up-regulates the gene expression of retinoic acid receptor alpha and gamma isoforms in embryo and adult rats. Biochem Biophys Res Commun 222: 395-400.
42.
Brown CC, Esterhazy D, Sarde AA, et al. (2015): Retinoic acid is essential for Th1 cell lineage stability and prevents transition to a Th17 cell program. Immunity 42: 499-511.
43.
Collins-Racie LA, Yang Z, Arai M, et al. (2009): Global analysis of nuclear receptor expression and dysregulation in human osteoarthritic articular cartilage: reduced LXR signaling contributes to catabolic metabolism typical of osteoarthritis. Osteoarthritis Cartilage 17: 832-842.
44.
Ghyselinck NB, Dupé V, Dierich A, et al. (1997): Role of the retinoic acid receptor beta (RAR) during mouse development. Int J Dev Biol 41: 425-447.
45.
Dzhagalov I, Chambon P, He YW (2007): Regulation of CD8+ T lymphocyte effector function and macrophage inflammatory cytokine production by retinoic acid receptor gamma. J Immunol 178: 2113-2121.
46.
Hall JA, Cannons JL, Grainger JR, et al. (2011): Essential role for retinoic acid in the promotion of CD4(+) T cell effector responsesvia retinoic acid receptor alpha. Immunity 34: 435-447.
47.
Sucov H, Murakami K, Evans R (1990): Characterization of an autoregulated response element in the mouse retinoic acid receptor type f8 gene (vitamin A/steroid receptor/transcription). Proc Natl Acad Sci U S A 87: 5392-5396.
48.
Weyand CM, Yang Z, Goronzy JJ (2014): T cell aging in rheumatoid arthritis. Curr Opin Rheumatol 26: 93-100.
49.
Brtko J, Rock E, Nezbedova P, et al. (2007): Age-related change in the retinoid X receptor beta gene expression in peripheral blood mononuclear cells of healthy volunteers: effect of 13-cis retinoic acid supplementation. Mech Ageing Dev 128: 594-600.
50.
Childs B, Valle D, Jimenez-Sanchez G (2001): The Inborn Error and Biochemical Individuality. In: The Metabolic & Molecular Bases of Inherited Disease. Sciver CS, Beaudet AL, Sly WS, Valle D (eds.). McGraw-Hill, New York 155-166.
51.
Glant TT, Mikecz K, Rauch TA (2014): Epigenetics in the pathogenesis of rheumatoid arthritis. BMC Med 12: 35.
52.
Lu Q (2013): The critical importance of epigenetics in autoimmunity. J Autoimmun 41: 1-5.
53.
Pike JW, Meyer MB, John HC, et al. (2015): Epigenetic histone modifications and master regulators as determinants of context dependent nuclear receptor activity in bone cells. Bone 81: 757-764.
54.
Sun SC, Chang JH, Jin J (2013): Regulation of nuclear factor-B in autoimmunity. Trends Immunol 34: 282-289.
55.
Benson M, Pino-Lagos K, Rosemblatt M, et al. (2007): All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med 204: 1765-1774.
56.
Kagechika H, Shudo K (2005): Synthetic retinoids: recent developments concerning structure and clinical utility. J Med Chem 48: 5875-5883.
57.
Takeuchi H, Yokota-Nakatsuma A, Ohoka Y, et al. (2013): Retinoid X receptor agonists modulate Foxp3+ regulatory T cell and Th17 cell differentiation with differential dependence on retinoic acid receptor activation. J Immunol 191: 3725-3733.
58.
Asquith DL, Miller AM, Hueber AJ, et al. (2009): Liver X receptor agonism promotes articular inflammation in murine collagen-induced arthritis. Arthritis Rheum 60: 2655-2665.
59.
Asquith DL, Miller AM, Reilly J, et al. (2011): Simultaneous activation of the liver X receptors (LXR and LXR) drives murine collagen-induced arthritis disease pathology. Ann Rheum Dis 70: 2225-2228.
Share
RELATED ARTICLE
| eISSN: | 1644-4124 |
| ISSN: | 1426-3912 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
